Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.
Login9 requirements across 5 categories
Sign up to view complete requirements and analysis
5 documents available with AI summaries
Bidders must submit Forms 1 and 2, confirm compliance with sanctions, and declare trade secrets to participate in the procurement of musculoskeletal system medications.
Form 1 is a mandatory submission form containing qualification questions and requirements that the bidder must answer.
The bidder must complete Form 2, which includes a technical description and price breakdown table for the purchase of musculoskeletal system medications, filling in all yellow cells.
The tender evaluates bid costs, where the lowest price receives the maximum score, and this document outlines the evaluation criteria and methodology.
The tender pass is the bidder's own declaration, serving as preliminary proof of meeting qualification requirements, and includes conditions set by the contracting authority and the format of expected responses.
Sign up to view document summaries and analysis
This tender for musculoskeletal system medications is generally well-structured with clear requirements and a reasonable timeline. However, it lacks explicit evaluation criteria beyond price and has limited sustainability considerations.
The tender appears to comply with general legal requirements, including a clear procedure and proper CPV code. Deadlines are reasonable. No disputes are noted. The mention of sanctions compliance is a positive legal aspect.
The description of the procurement is clear, and the requirements for Forms 1 and 2 are documented. However, the absence of explicit evaluation criteria beyond price could lead to ambiguity in the assessment process.
Most basic information is present, including estimated value, deadlines, and duration (implied by the 24-month description). However, the contract duration is not explicitly stated as a separate field, and financing conditions are only referenced as 'Toodud lepingus'.
The tender promotes fairness through e-submission and e-procurement. Access to documents is implied to be full. The criteria for evaluation are primarily price-based, which is objective, but the lack of other criteria might limit competition for innovative solutions. No specific company tailoring is evident.
E-submission and e-procurement are supported. A document URL for the opening place is provided. The contract start date is not explicitly stated. Financing information is vague. The duration is implied but not a distinct field.
Key fields such as title, reference, organization, value, and deadlines are populated. Dates are logical, and there are no reported suspensions or disputes. The tender status is clear.
There is no explicit mention of green procurement, social aspects, or innovation. The tender is not indicated as EU funded. This area is underdeveloped.
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
Our procurement experts prepare everything. Proven to work — you review, approve, and submit.
Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required